Clinical Trial Update: Darbe Administration in Newborns Undergoing Cooling for Encephalopathy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating darbepoetin alfa administration in newborns undergoing therapeutic cooling for hypoxic ischemic encephalopathy, with the study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: University of Utah | Conditions: Hypoxic Ischemic Encephalopathy | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-05-22